Mclean Hospital

PTSD Related Content


McLean’s Milissa Kaufman Receives Cornelia B. Wilbur Award From International Society for the Study of Trauma and Dissociation

For her work in the assessment and treatment of acute stress disorder, post-traumatic stress disorder (PTSD), and dissociative disorders, McLean Hospital’s Milissa Kaufman, MD, PhD, was honored with the 2018 Cornelia B. Wilbur Award from the International Society for the Study of Trauma and Dissociation (ISSTD). The ISSTD is an international professional association that develops and...

BPD and PTSD Treatment Innovator Kicks Off Training Clinics at McLean

Martin Bohus, MD, an internationally recognized leader in the study and treatment of borderline personality disorder (BPD) and post-traumatic stress disorder (PTSD), recently presented clinical training sessions, a webinar, and a lecture at McLean Hospital. Through the clinical training sessions, Bohus, currently a visiting professor at McLean, provided guidance on his modification of dialectical...

Addressing the Consequences of Gun Violence & Trauma

One month ago today, our country was once again devastated by a senseless act of gun violence that has left the entire nation grieving the loss of innocent lives and thrown us into heated debates about constitutional rights, arming teachers, and mental illness and violence. I applaud the millions of students who peacefully demanded safer schools by walking out of class today and the people of all...

Gift Propels Trauma Research, Care, and Training to New Levels

McLean is home to a number of prominent clinicians who provide some of the country’s most specialized care for individuals suffering from complex post-traumatic stress disorder (PTSD). Its researchers are leading the scientific front by exploring the environmental, genetic, and neurobiological components of trauma-related disorders. And the hospital has a growing effort to disseminate...

A Handheld Treatment for PTSD?

With new discoveries by McLean Hospital researchers, a fast and effective treatment for PTSD, anxiety, and addiction disorders could be close at hand. Literally. Right now, work is underway to develop a handheld inhaler containing xenon gas that could be used to block traumatic memories as soon as they are experienced. Whether used in a clinical setting or self-administered in the real world,...

McLean Researchers Awarded Allowance for a Method to Treat PTSD and Other Disorders with Xenon Gas

Researchers from McLean Hospital have been issued a patent allowance for their invention involving the use of xenon gas to aid in the treatment of addiction and anxiety disorders such as post-traumatic stress disorder (PTSD). The allowance indicates that, pending administrative actions, a patent will be issued to Edward G. Meloni, PhD, an investigator in the Behavioral Genetics Laboratory at...

PTSD: Can Genetics Affect Your Risk?

A majority of the US population is exposed to a psychological trauma during their life. For certain people, such as police officers, firefighters, or soldiers, the risk of experiencing trauma is even greater. However, only a fraction of those who experience such events will develop post-traumatic stress disorder (PTSD) or other trauma-related psychiatric disorders. The diagnostic criteria for...

Helping Those in the Line of Duty

The LEADER (Law Enforcement, Active Duty, Emergency Responder) program has grown substantially in volume and scope since it was launched in 2013 following the Boston Marathon bombing, according to McLean’s Chief Medical Officer Joseph Gold, MD, who oversees LEADER across multiple clinical divisions and levels of care. Gold noted that McLean developed the initial pilot for LEADER thanks to a...

A Passion for Science and Collaboration

Standing well over six feet tall, with a hearty smile and disarming laugh, Kerry J. Ressler, MD, PhD, commands a room as he talks about his vision for advancing translational research to improve the health and well-being of patients, particularly in psychiatric care. And when Ressler speaks, it is clear that his work is as much a part of him as his slight southern drawl. He’s clearly...

New Postmortem Brain Collection for PTSD and TBI Research Launched at McLean Hospital

McLean Hospital, in partnership with Cohen Veterans Bioscience, has established a vital collection of postmortem brains to be used in research on post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) in veteran and civilian populations. According to McLean Hospital Chief Scientific Officer Kerry J. Ressler, MD, PhD, who along with colleague Sabina Berretta, MD, scientific...

Cohen Veterans Bioscience Launches Partnerships with McLean Hospital and the Broad Institute

Cohen Veterans Bioscience today announced two new collaborative partnership efforts that will provide critical research tools for understanding the underlying neurobiology and genetics of post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) with the goal of accelerating the development of first generation diagnostics and treatments. For the partnership with the Stanley Center...

New Study Indicates That Sense of Smell Could Play Major Role in New Approaches to Treating PTSD

For those who live with post-traumatic stress disorder (PTSD), the sense of smell could one day play a prominent role in treatment, according to researchers at McLean Hospital in Belmont, Massachusetts, who co-authored a paper published this week in the journal Proceedings of the National Academy of Sciences. The new paper “Extinction Reverses Olfactory Fear Conditioned Increases in Neuron...

Imaging Innovations: Two Groundbreaking Techniques Offer the Possibility of Direct Relief

Innovations in neuroimaging enable McLean scientists to investigate the structure and function of the brain to diagnose and develop treatments for many mental health conditions. Now two groundbreaking techniques go a step further: offering the possibility of direct relief from memories of traumatic events and bipolar or major depression. Edward G. Meloni, PhD, assistant psychologist (left), and...

Xenon Exposure Shown to Block Traumatic Memories: Potential New Treatment for People with PTSD

In a study published earlier this year, McLean Hospital researchers found that xenon gas, used in humans for anesthesia and diagnostic imaging, has the potential to be a treatment for post-traumatic stress disorder (PTSD) and other memory-related disorders. “In our study, we found that xenon gas has the capability of reducing memories of traumatic events,” says Edward G. Meloni, PhD...

LEADER Program: Helping First Responders and Military from Across the US

First responders are always quick to assist others, but are among the last to seek help themselves. In 2014, McLean Hospital launched a program with the goal of changing that trend. Following the 2013 bombing at the Boston Marathon and the subsequent manhunt that turned the city from a bustling metropolis to a battlefield, McLean Hospital recognized an overwhelming need for mental health...

Veterans Day Feature: John Rodolico

John Rodolico, PhD, treats adolescents with a variety of issues ranging from substance abuse to anxiety disorders. What some people might not know is that Rodolico is not only a psychologist at McLean but he was also a medical officer in the US Army Reserves for many years and now serves in the Massachusetts National Guard. In 2003, his reserve unit was called up to Iraq during the initial...

Department of Defense Grant Looks At Nicotine’s Role in PTSD

Researchers at McLean’s Behavioral Genetics Lab are using animal models to study the effects of nicotine on vulnerability to post-traumatic stress disorder (PTSD) in a study funded by the Department of Defense (DoD). While the three-year, $600,000 study still has a year left to go, preliminary findings suggest that use of nicotine may be helpful in preventing some of the core signs of PTSD...

Potential New Treatment for PTSD Discovered

McLean Hospital researchers are reporting that xenon gas, used in humans for anesthesia and diagnostic imaging, has the potential to be a treatment for post-traumatic stress disorder (PTSD) and other memory-related disorders. “In our study, we found that xenon gas has the capability of reducing memories of traumatic events,” said Edward G. Meloni, PhD, assistant psychologist at...

Xenon Exposure Shown to Erase Traumatic Memories

McLean Hospital researchers are reporting that xenon gas, used in humans for anesthesia and diagnostic imaging, has the potential to be a treatment for post-traumatic stress disorder (PTSD) and other memory-related disorders. “In our study, we found that xenon gas has the capability of reducing memories of traumatic events,” said Edward G. Meloni, PhD, assistant psychologist at...

Increased Brain Activity May Hold Key to Eliminating PTSD

In a new paper published in the current issue of Neuron, McLean Hospital and Harvard Medical School researchers report that increased activity in the medial prefrontal cortex (mPFC) of the brain is linked to decreased activity in the amygdala, the portion of the brain used in the creation of memories of events that scared those exposed. According to author Vadim Bolshakov, PhD, director of the...

Pages